医学临床研究
  2025年4月6日 星期日           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2024, Vol. 41 Issue (2): 188-191    DOI: 10.3969/j.issn.1671-7171.2024.02.009
  论著 本期目录 | 过刊浏览 | 高级检索 |
逍遥散加味颗粒联合中药塌渍外敷治疗桥本甲状腺炎患者的临床效果
王府存1, 李茂林2*
1.榆林市中医医院老年病科,陕西 榆林 719000;
2.西安市碑林区中医医院中医内科,陕西 西安 710001
Clinical Effect of Xiaoyaosan Jiawei Granule Combined Chinese Medicine for External Use in the Treatment of Hashimoto Thyroiditis
WANG Fucun, LI Maolin
Department of Geriatrics, Yulin Hospital of Traditional Chinese Medicine, Yunlin Shaanxi 719000
全文: PDF (1187 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】探讨逍遥散加味颗粒联合中药塌渍外敷治疗桥本甲状腺炎患者的临床效果。【方法】选取2020年1月至2021年12月榆林市中医医院与西安市碑林区中医医院收治的66例桥本甲状腺炎患者,按照随机数字表法分为对照组和观察组,每组33例。观察组患者给予逍遥散加味颗粒内服联合中药塌渍外敷治疗,对照组患者给予硒酵母片口服治疗,比较两组患者临床疗效及治疗前后甲状腺功能指标、甲状腺相关抗体水平以及中医症状体征评分。【结果】观察组治疗总有效率明显高于对照组(P<0.05);治疗后,两组促甲状腺激素(TSH)水平均下降,且观察组TSH水平显著低于对照组(P<0.05);治疗后,两组游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)水平较治疗前均显著升高,且观察组明显高于对照组(P<0.05);治疗后,两组血清甲状腺球蛋白抗体(TGAb)甲状腺过氧化酶抗体(TPOAb)水平较治疗前均显著降低(P<0.05),且观察组上述指标水平均显著低于对照组(P<0.05);治疗后,对照组神疲乏力、气短懒言、腰膝酸软、口干舌燥、消瘦、心悸、失眠、烦热、自汗盗汗、大便溏稀等中医症状体征评分均显著高于观察组(P<0.05)。【结论】逍遥散加味颗粒口服联合中药塌渍外敷治疗桥本甲状腺炎患者,可明显改善患者甲状腺功能并降低患者自身甲状腺抗体水平,同时可有效缓解患者临床症状体征,达到标本兼治的目的。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
王府存
李茂林
关键词 桥本病/中医药疗法逍遥散/药理学敷贴疗法治疗结果    
Abstract:【Objective】To investigate the clinical efficacy and application of Xiaoyaosan Jiawei Granule in combination with external application of traditional Chinese medicine (TCM) (named Tazi) in the treatment of Hashimoto's thyroiditis. 【Methods】A total of 66 patients with Hashimoto's thyroiditis treated in Yulin City Traditional Chinese Medicine Hospital and Xi'an Beilin District Traditional Chinese Medicine Hospital from January 2020 to December 2021 were selected as the study subjects. They were randomly allocated into two groups: a control group and a treatment group, each comprising 33 patients. Patients in the treatment group received oral administration of Xiaoyaosan Jiawei (flavor added granules) and external application of TCM (Tazi), while patients in the control group were treated with oral selenium yeast. The clinical efficacy, thyroid function indicators, thyroid-related antibody levels, and TCM symptom and sign scores of the two groups were compared. 【Results】The overall effectiveness rate of the treatment group was significantly greater than the control group (P<0.05). Thyroid-stimulating hormone (TSH) level decreased in both control and treatment groups after treatment; and the TSH level in the tratmentn group was significantly lower than that in the control group (P<0.05). The levels of free triiodothyronine (FT3) and free thyroxine (FT4) increased significantly in both groups after treatment, while levels of FT3 and FT4 in the treatment group were significantly higher those in the control group(P<0.05). Serum thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody (TGAb) levels significantly decreased after treatment in both groups (P<0.05), with significantly lower levels in the treatment group compared to the control group (P<0.05). Post-treatment, scores of TCM symptoms and signs such as fatigue, shortness of breath, weakness in the waist and knees, dry mouth and throat, weight loss, palpitations, insomnia, irritability, spontaneous and night sweats, and loose stools were significantly higher in the control group than in the treatment group (P<0.05). 【Conclusion】The combined treatment method of oral administration of Xiaoyaosan Jiawei and external application of TCM (Tazi) significantly improved thyroid function and reduced the levels of autoantibodies in patients, and effectively alleviated clinical symptoms and signs, achieving the purpose of treating both the root and the symptoms.
Key wordsHashimoto Disease/ ZY    Xiaoyaosan/PD    Plastering therapy    Treatment Outcome
收稿日期: 2022-10-21     
中图分类号:  R581.4  
通讯作者: *E-mail:1099109130@qq.com   
引用本文:   
王府存, 李茂林. 逍遥散加味颗粒联合中药塌渍外敷治疗桥本甲状腺炎患者的临床效果[J]. 医学临床研究, 2024, 41(2): 188-191.
WANG Fucun, LI Maolin. Clinical Effect of Xiaoyaosan Jiawei Granule Combined Chinese Medicine for External Use in the Treatment of Hashimoto Thyroiditis. JOURNAL OF CLINICAL RESEARCH, 2024, 41(2): 188-191.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2024.02.009     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2024/V41/I2/188
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn